Agonist-induced Internalization and Recycling of the Glucagon-like Peptide-1 Receptor in Transfected Fibroblasts and in Insulinomas
Overview
Affiliations
Glucagon-like peptide-1 (GLP-1) is the most potent stimulator of glucose-induced insulin secretion and its pancreatic beta-cell receptor is a member of a new subfamily of G-protein-coupled receptors which includes the receptors for vasoactive intestinal polypeptide, secretin and glucagon. Here we studied agonist-induced GLP-1 receptor internalization in receptor-transfected Chinese hamster lung fibroblasts using three different approaches. First, iodinated GLP-1 bound at 4 degrees C to transfected cells was internalized with a t 1/2 of 2-3 min following warming up of the cells to 37 degrees C. Secondly, exposure to GLP-1 induced a shift in the distribution of the receptors from plasma membrane-enriched to endosomes-enriched membrane fractions, as assessed by Western blot detection of the receptors using specific antibodies. Thirdly, continuous exposure of GLP-1 receptor-expressing cells to iodinated GLP-1 led to a linear accumulation of peptide degradation products in the medium following a lag time of 20-30 min, indicating a continuous cycling of the receptor between the plasma membrane and endosomal compartments. Potassium depletion and hypertonicity inhibited transferrin endocytosis, a process known to occur via coated pit formation, as well as GLP-1 receptor endocytosis. In contrast to GLP-1, the antagonist exendin-(9-39) did not lead to receptor endocytosis. Surface re-expression following one round of GLP-1 receptor endocytosis occurred with a half-time of about 15 min. The difference in internalization and surface re-expression rates led to a progressive redistribution of the receptor in intracellular compartments upon continuous exposure to GLP-1. Finally, endogenous GLP-1 receptors expressed by insulinoma cells were also found to be internalized upon agonist binding. Together our data demonstrate that the GLP-1 receptor is internalized upon agonist binding by a route similar to that taken by single transmembrane segment receptors. The characterization of the pathway and kinetics of GLP-1-induced receptor endocytosis will be helpful towards understanding the role of internalization and recycling in the control of signal transduction by this receptor.
Zhang W, Wu L, Qu R, Liu T, Wang J, Tong Y Heliyon. 2024; 10(16):e35424.
PMID: 39220963 PMC: 11365324. DOI: 10.1016/j.heliyon.2024.e35424.
Thorens B, Hodson D Diabetes. 2024; 73(7):1027-1031.
PMID: 38900951 PMC: 11189827. DOI: 10.2337/dbi24-0025.
Cristelo C, Nunes R, Pinto S, Marques J, Gama F, Sarmento B ACS Pharmacol Transl Sci. 2023; 6(10):1544-1560.
PMID: 37854630 PMC: 10580391. DOI: 10.1021/acsptsci.3c00218.
Wright S, Motso A, Koutsilieri S, Beusch C, Sabatier P, Berghella A Nat Commun. 2023; 14(1):6243.
PMID: 37813859 PMC: 10562414. DOI: 10.1038/s41467-023-41893-4.
A Peptide in a Pill - Oral Semaglutide in the Management of Type 2 Diabetes.
Selvarajan R, Subramanian R Diabetes Metab Syndr Obes. 2023; 16:1709-1720.
PMID: 37312901 PMC: 10259523. DOI: 10.2147/DMSO.S385196.